Singapore markets closed

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.10+0.15 (+1.89%)
At close: 04:00PM EDT
7.75 -0.35 (-4.32%)
After hours: 06:34PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.10B
Enterprise value -297.53M
Trailing P/E 5.92
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)27.51
Price/book (mrq)0.69
Enterprise value/revenue -7.53
Enterprise value/EBITDA 0.45

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 3-67.52%
S&P500 52-week change 323.06%
52-week high 327.48
52-week low 37.72
50-day moving average 310.06
200-day moving average 310.84

Share statistics

Avg vol (3-month) 31.08M
Avg vol (10-day) 3849.15k
Shares outstanding 5135.84M
Implied shares outstanding 6135.84M
Float 888.97M
% held by insiders 114.14%
% held by institutions 175.84%
Shares short (28 Mar 2024) 44.96M
Short ratio (28 Mar 2024) 45.16
Short % of float (28 Mar 2024) 46.17%
Short % of shares outstanding (28 Mar 2024) 43.67%
Shares short (prior month 29 Feb 2024) 45.08M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 0.00%
Operating margin (ttm)-724.57%

Management effectiveness

Return on assets (ttm)-17.48%
Return on equity (ttm)-33.54%

Income statement

Revenue (ttm)86.18M
Revenue per share (ttm)0.64
Quarterly revenue growth (yoy)-66.00%
Gross profit (ttm)N/A
EBITDA -640.57M
Net income avi to common (ttm)-615.06M
Diluted EPS (ttm)-4.59
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.52B
Total cash per share (mrq)11.27
Total debt (mrq)124.54M
Total debt/equity (mrq)7.83%
Current ratio (mrq)9.06
Book value per share (mrq)11.80

Cash flow statement

Operating cash flow (ttm)-778.79M
Levered free cash flow (ttm)-596.45M